# C5a Receptor Expression - COVID-19 (C5-COV)

> **NCT04369820** · NA · COMPLETED · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 61 (actual)

## Conditions studied

- COVID-19

## Interventions

- **OTHER:** draw blood

## Key facts

- **NCT ID:** NCT04369820
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-31
- **Primary completion:** 2020-09-30
- **Final completion:** 2023-08-09
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2023-08-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04369820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04369820, "C5a Receptor Expression - COVID-19 (C5-COV)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04369820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*